People who have a high blood cholesterol levels are often given a statin medication (e.g. Lipitor, Crestor, Zocor) to prevent a heart attack or stroke. Unfortunately, not everyone who is given a statin will achieve a blood cholesterol goal to achieve the best protection against having heart attack or stroke. Also, some people find that they have a hard time tolerating a statin. So scientists are constantly looking for new medications that can help out when these circumstances appear. A new class of cholesterol lowering medications, called PCSK9 inhibitors, has been developed to add to a statin for these patients.
A research study is beginning at National Clinical Research to add a PCSK9 inhibitor, which has been FDA approved, to the statin therapy of patients who have a high risk of a heart attack or stroke. This study will evaluate a new device to administer the medication. In this 3 month study, all patients will receive the active PCSK9 therapy at no cost.
- Have a LDL-cholesterol > 70 mg/dL while receiving statin therapy
- Taking atorvastatin (Lipitor) 20 mg or 40 mg OR rosuvastatin (Crestor) 10 mg or 20 mg daily
- Have one of the following conditions which raise the risk of a heart attack or stroke:
- Have had a heart attack or stroke
- Have had a stent placed to open up an artery or had by-pass surgery
- Have poor circulation in legs
- Have chronic kidney disease
- Have diabetes
16 Weeks – 12 Visits
May receive up to $600 for your participation.